Drug Information Analysis Service

Phenytoin. In: McEvoy GK ed. American hospital formulary service drug information. Bethesda, MD: American Society of Hospital Pharmacists, 1991: 1216.

Kimball OP . The treatment of epilepsy with sodium-diphenylhydantoinate. JAMA 1939; 112: 1224–5.

Seymour RA Heasman PA . Drugs and the periodontium. J Clin Periodontol 1988; 15: 1–16.

Seymour RA . Calcium channel blockers and gingival overgrowth. Br Dent J 1991; 170: 376–9.

Lederman D Lumerman H Reuben S Freedman P . Gingival hyperplasia associated with nifedipine therapy. Oral Surg 1984; 57: 620–2.

Ramon Y Behar S Kishon Y Engelberg IS . Gingival hyperplasia caused by nifedipine: A preliminary report. Int J Cardiol 1984; 5: 195–204.

Lucas R Howell LP Wall BA . Nifedipine-induced gingival hyperplasia. J Periodontol 1985; 56: 211–5.

Barak S Engelberg IS Hiss J . Gingival hyperplasia caused by nifedipine. J Periodontol 1987; 58: 639–42.

Bencini PL Crosti C Sala F Montagnino G Tarantino A Menni S . Gingival hyperplasia by nifedipine. Acta Derm Venereol (Stockh) 1985; 65: 362–5.

Van der Wall E Tuinzing DB Hes J . Gingival hyperplasia induced by nifedipine, an arterial vasodilating drug. Oral Surg Oral Med Oral Pathol 1985; 60: 38–40.

Veraldi S Piferi M Marini D . Gingival hyperplasia following nifedipine therapy (letter). Clin Exp Dermatol 1989; 14: 93.

Bezan KT . Gingival enlargement secondary to nifedipine therapy. Gen Dent 1987; 35: 353–4.

Tagawa T Nakamara H Murata M . Marked gingival hyperplasia induced by nifedipine. Int J Oral Maxillofac Surg 1989; 19: 72–3.

Shaftic AA Widdup LL Abate MA Jacknowitz AI . Nifedipine-induced gingival hyperplasia. Drug Intell Clin Pharm 1986; 20: 602–5.

Pernu H Oikarinen K Hietanen J Knuuttila M . Verapamil-induced gingival overgrowth: A clinical, histologic, and biochemic approach. J Oral Pathol Med 1989; 18: 422–5.

Bowman JM Levy BA Grubb RV . Gingival overgrowth induced by diltiazem. Oral Surg Oral Med Oral Pathol 1988; 65: 183–5.

Giustiniani S Robustelli Dell Cuna F Marieni M . Hyperplastic gingivitis during diltiazem therapy. Int J Cardiol 1987; 15: 247–9.

Nyska A Waner T Pirak M Galiano A Zlotogorski A . Gingival hyperplasia in rats induced by oxodipine: A calcium channel blocker. J Periodont Res 1990: 25: 65–8.

Sooriyamoorthy M Gower DB Eley BM . Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporine. J Periodont Res 1990; 25: 25–30.

Ekbom KA . Restless legs syndrome. Neurology 1960; 10: 868–73.

Nielsen VK . The peripheral nerve function in chronic renal failure. Acta Med Scand 1971; 190: 105–11.

Akpinar S . Restless legs syndrome treatment with dopaminergic drugs. Clin Neuropharmacol 1987; 10: 69–79.

Krueger BR . Restless legs syndrome and periodic movements of sleep. Mayo Clin Proc 1990; 65: 999–1006.

Sandyk R Bernick C Lee SM Stern LZ Iacono RP Bamford CR . L-dopa in uremic patients with the restless legs syndrome. Intern J Neurosci 1987; 35: 233–35.

Brodeur C Montplaisir J Godbout R Marinier R . Treatment of restless legs syndrome and periodic movements during sleep with l-dopa: A double blind, controlled study. Neurology 1988; 38: 1845–8.

Von Scheele C . Levodopa in restless legs. Lancet 1986; 8: 426–7.

Montplaisir J Godbout R Poirier G Bedard MA . Restless legs syndrome and periodic movements in sleep: Physiopathology and treatment with l-dopa. Clin Neuropharmacol 1986; 9: 456–63.

Von Scheele C Kempi V . Long-term effect of dopaminergic drugs in restless legs: A 2-year follow-up. Arch Neurol 1990; 47: 1223–4.

Eldridge R . Torticollis. In: Wyngaarden JB Smith LH eds. Cecil's textbook of medicine. 18th ed. Philadelphia: WB Saunders, 1988: 2149–51.

Fahn S . Concept and classification of dystonia. Adv Neurol 1988; 50: 1–7.

Taylor P . Neuromuscular blocking agents. In: Gilman AG Rall TW Nies AS Taylor P eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. Elmsford, NY: Pergamon Press, 1990: 173.

Tsui J Eisen A Stoessl AS Calne S Calne DB . Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986; 2: 245–7.

Tsui J Eisen A Calne DB . Botulinum toxin in spasmodic torticollis. Adv Neurol 1988; 50: 593–7.

Gelb DJ Lowenstein DH Aminoff MJ . Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 1989; 39: 80–4.

Blackie JD Lees AJ . Botulinum toxin treatment in spasmodic torticollis. J Neurol, Neurosurg Psychiatry 1990; 53: 540–3.

Maurri S Barontini F . Responsiveness of idiopathic spasmodic torticollis to botulinum A toxin injection: A critical evaluation of five cases. Clin Neurol Neurosurg 1990; 92: 165–8.

Lorentz IT Subramaniam SS Yiannikas C . Treatment of idiopathic spasmodic torticollis with botulinum A toxin: A pilot study of 19 patients. Med J Aust 1990: 152: 528–30.

Greene P Kang U Fahn S Brin M Moskowitz C Flaster E . Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 1990; 40: 1213–8.

Jankovic J Brin M . Drug therapy: Therapeutic uses of botulinum toxin. New Engl J Med 1991; 324: 1186–94.